CHILDREN'S FLONASE ALLERGY RELIEF OTC
Generic Name and Formulations:
Fluticasone propionate 50mcg; per nasal spray.
Indications for CHILDREN'S FLONASE ALLERGY RELIEF:
Relieves symptoms of hay fever or other upper respiratory allergies.
Initially 2 sprays in each nostril once daily for Week 1, then 1 or 2 sprays in each nostril once daily as needed for Week 2 through 6 months. Reevaluate after 6 months.
<4yrs: not recommended. Use for the shortest duration necessary to achieve response. ≥4yrs: 1 spray in each nostril once daily. Reevaluate after 2 months.
Not for treating asthma. Injury or surgery to nose that is not fully healed: not recommended. Discontinue if exposed to chicken pox, measles, or tuberculosis. Glaucoma. Cataracts. Discontinue if whistling sound from nose, visual disturbances, severe or frequent nosebleeds occur. Discontinue if no improvement within 7 days after starting or if new symptoms (eg, facial pain, nasal discharge) develop. Avoid eyes or mouth. Pregnancy. Nursing mothers.
Caution with concomitant ritonavir, ketoconazole, other steroids.
Stinging, sneezing, headaches, dry/irritated nose or throat, nosebleeds, whistling sound, blurred or reduced vision, reduced growth rate in children, allergic reaction (discontinue if occurs).
Spray—9.9mL (60 sprays), 15.8mL (120 sprays); Children's—2 × 9.9mL (2 × 60 sprays)
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Free vs Total Serum 25(OH)D as Biomarkers for Bone Health in Older Women
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk